Table 2. The mean hematological value of neutrophils (×109/L), platelets (×109/L), lymphocytes (×109/L), monocytes (×109/L) by patient's demographic and clinical characteristics.
| Neu (mean±SD) |
P | Plt (mean±SD) |
P | Lym (mean±SD) |
P | Mon (mean±SD) |
P | |
|---|---|---|---|---|---|---|---|---|
| Age (years) | 0.438 | <0.001 | <0.001 | 0.179 | ||||
| <60 | 3.92 ±1.40 | 192.22±55.25 | 2.08±0.68 | 0.49±0.17 | ||||
| ≥60 | 3.85±1.35 | 175.08±53.04 | 1.80±0.59 | 0.48±0.17 | ||||
| Gender | 0.002 | 0.783 | 0.048 | 0.007 | ||||
| Male | 3.90±1.37 | 183.37±54.87 | 1.94±0.65 | 0.49±0.17 | ||||
| Female | 3.03±1.29 | 180.25±50.94 | 1.68±0.53 | 0.39±0.15 | ||||
| Smoking history | 0.994 | 0.059 | 0.014 | 0.020 | ||||
| No | 3.88±1.52 | 178.48±51.55 | 1.86±0.65 | 0.46±0.17 | ||||
| Yes | 3.88±1.30 | 185.55±56.10 | 1.97±0.65 | 0.49±0.18 | ||||
| Drinking history | 0.982 | 0.350 | 0.118 | 0.021 | ||||
| No | 3.88±1.41 | 182.02±53.79 | 1.91±0.64 | 0.47±0.17 | ||||
| Yes | 3.88±1.31 | 185.40±56.34 | 1.98±0.66 | 0.50±0.17 | ||||
| Tumor subsite | 0.006 | 0.029 | 0.056 | <0.001 | ||||
| Supraglottic | 4.12±1.51 | 191.21±64.58 | 1.86±0.61 | 0.52±0.18 | ||||
| Glottic & Subglottic | 3.81±1.32 | 180.91±51.26 | 1.96±0.66 | 0.47±0.17 | ||||
| Tumor size | <0.001 | <0.001 | 0.026 | <0.001 | ||||
| ≤2cm | 3.69±1.27 | 178.24±50.25 | 1.97±0.66 | 0.46±0.16 | ||||
| >2cm | 4.23±1.48 | 192.44±61.12 | 1.87±0.63 | 0.51±0.19 | ||||
| Tumor stage | <0.001* | <0.001* | 0.002* | <0.001* | ||||
| T1 | 3.73±1.24 | 176.87±49.13 | 2.00±0.69 | 0.46±0.16 | ||||
| T2 | 3.74±1.28 | 178.28±50.52 | 1.96±0.67 | 0.48±0.16 | ||||
| T3 | 4.00±1.46 | 188.30±60.01 | 1.91±0.59 | 0.49±0.17 | ||||
| T4 | 4.77±1.37 | 214.08±61.87 | 1.67±0.54 | 0.58±0.25 | ||||
| Lymph node stage | 0.017 | 0.724 | 0.280 | 0.044 | ||||
| N0 | 3.84±1.34 | 183.07±53.10 | 1.94±0.65 | 0.48±0.17 | ||||
| N+ | 4.21±1.55 | 185.00±66.37 | 1.87±0.67 | 0.51±0.18 | ||||
| Clinical stage | <0.001** | 0.001** | 0.012*** | <0.001*** | ||||
| I | 3.73±1.24 | 176.87±49.13 | 2.00±0.69 | 0.46±0.16 | ||||
| II | 3.71±1.25 | 180.10±50.81 | 1.96±0.66 | 0.47±0.16 | ||||
| III | 3.97±1.43 | 185.63±57.09 | 1.91±0.61 | 0.48±0.16 | ||||
| IV | 4.46±1.62 | 199.00±66.30 | 1.78±0.61 | 0.55±0.23 | ||||
| Differentiation grade | 0.398 | 0.776 | 0.244 | 0.863 | ||||
| Well & moderate | 3.93±1.38 | 184.87±55.49 | 1.92±0.64 | 0.49±0.18 | ||||
| Poor | 4.41±1.55 | 181.93±52.75 | 2.06±0.65 | 0.48±0.15 |
Bold values represent that P were two-sided and P<0.05 was statistically significant.
Abbreviations: Neu, neutrophils (×109/L); Plt, platelets (×109/L); Lym, lymphocytes (×109/L); Mon, monocytes (×109/L).
*P<0.05 for the significant difference between the mean hematological parameters of T1, T2 and T3 categories and of T4 categories, respectively (1-way ANOVA with the Bonferroni post hoc test).
**P<0.05 for the significant difference between the mean hematological parameters of I, II and III stages and of IV stages, respectively (1-way ANOVA with the Bonferroni post hoc test).
***P<0.05 for the significant difference between the mean hematological parameters of I and II stages and of IV stages, respectively (1-way ANOVA with the Bonferroni post hoc test).